A preclinical study of mice found that anti–tumor necrosis factor treatment reduced the expression of proinflammatory cytokines in the thyroid gland, leading to less inflammation,27 and 2 clinical studies reported improved thyroid function in patients with RA and hypothyroidism who received anti–tumor necrosis factor treatment.28,29. The gene discussed is TNF; the disease is rheumatoid arthritis.